| Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies MI Nounou, F ElAmrawy, N Ahmed, K Abdelraouf, S Goda, ... Breast cancer: basic and clinical research 9, BCBCR. S29420, 2015 | 479 | 2015 |
| Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa VH Tam, KT Chang, K Abdelraouf, CG Brioso, M Ameka, LA McCaskey, ... Antimicrobial agents and chemotherapy 54 (3), 1160-1164, 2010 | 225 | 2010 |
| Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design K Abdelraouf, KH Braggs, T Yin, LD Truong, M Hu, VH Tam Antimicrobial agents and chemotherapy 56 (9), 4625-4629, 2012 | 134 | 2012 |
| Pharmacokinetics and renal disposition of polymyxin B in an animal model K Abdelraouf, J He, KR Ledesma, M Hu, VH Tam Antimicrobial agents and chemotherapy 56 (11), 5724-5727, 2012 | 92 | 2012 |
| Uptake of polymyxin B into renal cells K Abdelraouf, KT Chang, T Yin, M Hu, VH Tam Antimicrobial agents and chemotherapy 58 (7), 4200-4202, 2014 | 69 | 2014 |
| Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa K Abdelraouf, S Kabbara, KR Ledesma, K Poole, VH Tam Journal of Antimicrobial Chemotherapy 66 (6), 1311-1317, 2011 | 67 | 2011 |
| Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report ALH Kwa, K Abdelraouf, JGH Low, VH Tam Clinical Infectious Diseases 52 (10), 1280-1281, 2011 | 58 | 2011 |
| Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model J He, K Abdelraouf, KR Ledesma, DSL Chow, VH Tam International journal of antimicrobial agents 42 (6), 559-564, 2013 | 55 | 2013 |
| Predicting bacterial fitness cost associated with drug resistance B Guo, K Abdelraouf, KR Ledesma, M Nikolaou, VH Tam Journal of antimicrobial chemotherapy 67 (4), 928-932, 2012 | 53 | 2012 |
| Metallo-β-lactamase resistance in Enterobacteriaceae is an artefact of currently utilized antimicrobial susceptibility testing methods TE Asempa, K Abdelraouf, DP Nicolau Journal of Antimicrobial Chemotherapy 75 (4), 997-1005, 2020 | 43 | 2020 |
| Quantitative impact of neutrophils on bacterial clearance in a murine pneumonia model B Guo, K Abdelraouf, KR Ledesma, KT Chang, M Nikolaou, VH Tam Antimicrobial agents and chemotherapy 55 (10), 4601-4605, 2011 | 41 | 2011 |
| Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung … LM Avery, K Abdelraouf, DP Nicolau Antimicrobial Agents and Chemotherapy 62 (11), 10.1128/aac. 00948-18, 2018 | 38 | 2018 |
| In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase … K Abdelraouf, S Almarzoky Abuhussain, DP Nicolau Journal of Antimicrobial Chemotherapy 75 (12), 3601-3610, 2020 | 33 | 2020 |
| In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh … SS Almarzoky Abuhussain, LM Avery, K Abdelraouf, DP Nicolau Antimicrobial Agents and Chemotherapy 63 (1), 10.1128/aac. 01931-18, 2019 | 32 | 2019 |
| Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a … JM Kidd, K Abdelraouf, DP Nicolau Journal of Antimicrobial Chemotherapy 75 (1), 149-155, 2020 | 30 | 2020 |
| Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine … IH Chen, JM Kidd, K Abdelraouf, DP Nicolau Antimicrobial Agents and Chemotherapy 63 (12), 10.1128/aac. 01558-19, 2019 | 30 | 2019 |
| Meropenem–nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model TE Asempa, A Motos, K Abdelraouf, C Bissantz, C Zampaloni, DP Nicolau International journal of antimicrobial agents 55 (2), 105838, 2020 | 29 | 2020 |
| In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model ML Monogue, J Tabor-Rennie, K Abdelraouf, DP Nicolau Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 00233-19, 2019 | 29 | 2019 |
| In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in the Murine … K Abdelraouf, SM Stainton, DP Nicolau Antimicrobial Agents and Chemotherapy 63 (7), 10.1128/aac. 00145-19, 2019 | 28 | 2019 |
| Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models K Abdelraouf, DP Nicolau Antimicrobial Agents and Chemotherapy 61 (1), 10.1128/aac. 01957-16, 2017 | 27 | 2017 |
